Directory

>

Boguslawa Wilk

Boguslawa Wilk

Executive Director, Analytical Development | Lexicon Pharmaceuticals, Inc.

United States

View contact details (it's free)

Boguslawa Wilk

Summary

Boguslawa Wilk is an accomplished Executive Director in Analytical Development at Lexicon Pharmaceuticals, bringing over two decades of experience in the pharmaceutical industry. With a strong foundation in analytical chemistry, she has a proven track record of leading teams through complex drug development processes from early stages to commercialization. Her expertise encompasses a wide array of analytical techniques including HPLC and mass spectrometry, as well as regulatory compliance and quality assurance. Boguslawa is recognized for her strategic thinking and has been instrumental in mentoring the next generation of scientists. She has worked closely with regulatory bodies to ensure adherence to stringent guidelines, showcasing her commitment to excellence in pharmaceutical development. Her academic background includes a PhD in Organic Physical Chemistry from Rutgers University and a Master's degree from Warsaw University of Technology. Boguslawa's unique blend of scientific knowledge and leadership skills positions her as a key player in advancing pharmaceutical innovations.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Immigrant

Professional interests

Industry-specific interests

Emerging Technologies

Leadership Development

Organisational experience

Corporate Experience

Boguslawa Wilk

Work Experience

company logo

Executive Director, Analytical Development at

Lexicon Pharmaceuticals, Inc.

February 2024 - Present

company logo

Senior Director, Analytical Development at

Lexicon Pharmaceuticals, Inc.

February 2017 - February 2024

company logo

Director, Analytical Development at

LEXICON PHARMACEUTICALS

February 2014 - February 2017

company logo

Associate Director at

LEXICON PHARMACEUTICALS

January 2011 - January 2014

company logo

Associate Director at

Pfizer, Inc.

September 2009 - January 2011

company logo

Associate Director at

Wyeth Research

January 2008 - October 2009

company logo

Section Head at

Wyeth Research

January 2004 - January 2007

company logo

Principal Research Scientist I at

Wyeth Research

January 2003 - January 2004

company logo

Senior Research Scientist II at

Wyeth Research

January 1999 - January 2003

company logo

Senior Research Scientist I at

Wyeth Research

January 1996 - January 1999

💼

Adjunct/Lecturer at

Suny At Plattsburgh

January 1994 - January 1995

company logo

Postdoctoral Research Associate and Research Assistant Professor at

University of Pittsburgh

January 1989 - January 1992

Logos provided by Logo.dev

Boguslawa Wilk

Education

Rutgers University, Phd

January 1985 - January 1990

Frequently Asked Questions about Boguslawa Wilk

What is Boguslawa Wilk email address?

Boguslawa Wilk's primary email address is *****@lexpharma.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Boguslawa Wilk work for?

Boguslawa Wilk is a Executive Director, Analytical Development at Lexicon Pharmaceuticals, Inc., a company specializing in Biological products, except diagnostic.

Where Boguslawa Wilk graduated from?

Boguslawa Wilk holds a degree in Organic Physical Chemistry from Rutgers University.

How can I directly contact Boguslawa Wilk?

To contact Boguslawa Wilk directly, you can use the email address *****@lexpharma.com. Complete contact information is available upon registration with Muraena.

Is Boguslawa Wilk an immigrant?

Yes, Boguslawa Wilk is an immigrant and currently based in United States

Who is Boguslawa Wilk?

Boguslawa Wilk is an accomplished Executive Director in Analytical Development at Lexicon Pharmaceuticals, bringing over two decades of experience in the pharmaceutical industry. With a strong foundation in analytical chemistry, she has a proven track record of leading teams through complex drug development processes from early stages to commercialization. Her expertise encompasses a wide array of analytical techniques including HPLC and mass spectrometry, as well as regulatory compliance and quality assurance. Boguslawa is recognized for her strategic thinking and has been instrumental in mentoring the next generation of scientists. She has worked closely with regulatory bodies to ensure adherence to stringent guidelines, showcasing her commitment to excellence in pharmaceutical development. Her academic background includes a PhD in Organic Physical Chemistry from Rutgers University and a Master's degree from Warsaw University of Technology. Boguslawa's unique blend of scientific knowledge and leadership skills positions her as a key player in advancing pharmaceutical innovations.

Boguslawa`s contact details

mail

*****@lexpharma.com

Colleagues

avatar
Alan Wilson

V P, DMPK, Toxicology, Pathology

avatar
Godfried Owusu-Ababio

Vice President, Technical Operations

avatar
Suma Gopinathan

Vice President, Clinical Development

avatar
Tom Garner

Senior Vice President & Chief Commercial Officer

avatar
Robert Scala

VP, Business Operations and Launch Planning

avatar
Kyle Burt

Executive Director , Information Operations

avatar
Dixon Terry

Vice President, Compliance

avatar
Craig Granowitz

Chief Medical Officer

avatar
Brian Crum

Senior Vice President and General Counsel

avatar
Iain Paterson

President

View Contact details (it's free)
Request Profile Removal